Personalized gene therapy benefits twins with juvenile Batten disease
A personalized treatment called Zebronkysen led to gains in function for twin girls with juvenile Batten disease in a clinical study, surpassing the expectations of researchers who had hoped merely to slow disease progression. “We did not expect to see improvement in addition to a slowing of decline,” Yael…